Repeated low-level red-light therapy for myopia
Clinical studies conducted worldwide have reported reductions in axial elongation and slowed myopia progression in children aged 3–16 years, with some trials reporting effects of up to 87.7%. Our RLRL technology provides clinicians with an evidence-based, non-invasive option for managing myopia within clinical practice.
RLRL therapy is a clinically supported, non-invasive treatment for children aged 3–16 to help slow the progression of myopia—administered at home under the supervision of an eye-care professional.
Your optometrist will explain how the device works, whether it is suitable for your child, and how it fits within the range of available myopia management options.
Request a Demo Device Find a Clinic Near You
Pioneering Myopia Management
Eyerising International has developed the Eyerising Myopia Management Device, a patented RLRL therapy which can be used at home. Patient use of our device is monitored under clinical supervision.
The device is designed for home use with 3-minute treatment sessions, twice daily, five days per week, with at least 4 hours between sessions.
The Eyerising Myopia Management Device is available exclusively through optometrists and ophthalmologists. Outcomes may vary for each patient.
Eyerising International is an Australian medical technology company dedicated to advancing repeated low-level red-light (RLRL) therapy for childhood myopia management across the globe.
With approximately 1,500 patients across 30+ countries and more than 80,000 patients supported through our network in China, we partner with clinicians, researchers, and distributors to deliver safe, effective, and monitored myopia control solutions.
Our mission is to make evidence-based myopia management accessible to children and families worldwide—through rigorous science, trusted clinical relationships, and purpose-built technology.
What We Offer
A complete ecosystem designed to support clinicians and patients at every step of the myopia management journey.
Online Monitoring System
A secure, cloud-based platform giving clinicians real-time visibility into patient treatment compliance, session data, and progress—from anywhere in the world.
Myopia Management Device
A compact, non-invasive home-use device that delivers patented RLRL therapy in just three-minute sessions—designed for daily use by children aged 3–16 under clinical supervision.
Customer Support
Dedicated technical support, onboarding resources, and patient guidance tools to ensure clinicians and families get the most from every treatment session.
"By collaborating with clinicians, researchers, and partners worldwide, we aim to advance the science and practice of myopia management for future generations."
"Our mission is to support eye-care professionals through research, collaboration, and innovation in myopia management."
Ready to Learn More?
Connect with our team to explore the Eyerising device and discover how our complete solution fits your practice.